COVID-19 and steroid therapy: Impact on diabetes
- PMID: 32778507
- PMCID: PMC7391982
- DOI: 10.1016/j.pcd.2020.07.013
COVID-19 and steroid therapy: Impact on diabetes
Comment on
-
COVID-19 and diabetes: What does the clinician need to know?Prim Care Diabetes. 2020 Oct;14(5):558-563. doi: 10.1016/j.pcd.2020.06.010. Epub 2020 Jul 3. Prim Care Diabetes. 2020. PMID: 32654982 Free PMC article. Review.
References
-
- Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 — RECOVERY Trial [Internet]. [cited 2020 Jun 18]. Available from: https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-....
-
- Qi D., Pulinilkunnil T., An D., Ghosh S., Abrahani A., Pospisilik J.A. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. Diabetes. 2004;53(July (7)):1790–1797. - PubMed
-
- RECOVERY Collaborative Group, Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L. Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N. Engl. J. Med. 2020;(July)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
